NDC 63323-540 – Heparin Sodium

Heparin Sodium 1000 [USP'U]/mL · Injection, Solution · Intravenous, Subcutaneous

Human Prescription Drug 1 recall

Product NDC63323-540

Product details

Brand name
Heparin Sodium
Generic name
Heparin Sodium
Labeler
Fresenius Kabi USA, LLC
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Marketing category
NDA · NDA017029
Marketed since
November 4, 2019
Listing expires
December 31, 2027
Pharmacologic class
Anti-coagulant; Unfractionated Heparin

Active ingredients

Uses, dosage, side effects and warnings for Heparin Sodium →

Package NDC codes (4)

Package NDCDescriptionSince
63323-540-1325 VIAL in 1 TRAY (63323-540-13) / 1 mL in 1 VIAL (63323-540-03)Nov 4, 2019
63323-540-1525 VIAL in 1 TRAY (63323-540-15) / 10 mL in 1 VIAL (63323-540-05)Nov 4, 2019
63323-540-3625 VIAL in 1 TRAY (63323-540-36) / 30 mL in 1 VIAL (63323-540-33)Nov 4, 2019
63323-540-6725 VIAL, MULTI-DOSE in 1 TRAY (63323-540-67) / 10 mL in 1 VIAL, MULTI-DOSE (63323-540-07)Mar 25, 2020

Recalls mentioning this NDC

Other Heparin Sodium products